Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
flipboard.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
Welcome to Flipboard on Mastodon. A place for our community of curators and enthusiasts to inform and inspire each other. If you'd like to join please request an invitation via the sign-up page.

Administered by:

Server stats:

1.2K
active users

flipboard.social: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.7

#cassavasciences

0 posts0 participants0 posts today
El Club De Los Físicos Muertos<p>As u already know <a href="https://mastodon.social/tags/CassavaSciences" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CassavaSciences</span></a>' justification for going to phase 3 trials was that it slowed down cognitive deterioration of mild stage of <a href="https://mastodon.social/tags/Alzheimer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Alzheimer</span></a>'s patients for two years. NOT TRUE.<br>It is questionable that would approve a drug for which reasons for its effects is unknown</p>
El Club De Los Físicos Muertos<p>Remi Barbier, chairman president and CEO of <a href="https://mastodon.social/tags/CassavaSciences" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CassavaSciences</span></a>, has resigned from the board of directors. <a href="https://mastodon.social/tags/Cassava" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Cassava</span></a> is the company backing <a href="https://mastodon.social/tags/simufilam" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>simufilam</span></a>, a drug for mild to moderate n <a href="https://mastodon.social/tags/Alzheimer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Alzheimer</span></a>'s disease patients now in stage 3 clinical trials</p>
ExploreLive feeds
About